![](/img/cover-not-exists.png)
A novel dipeptidyl peptidase-4 inhibitor, alogliptin (SYR-322), is effective in diabetic rats with sulfonylurea-induced secondary failure
Tomoko Asakawa, Yusuke Moritoh, Osamu Kataoka, Nobuhiro Suzuki, Koji Takeuchi, Hiroyuki OdakaVolume:
85
Year:
2009
Language:
english
DOI:
10.1016/j.lfs.2009.04.024
File:
PDF, 617 KB
english, 2009